8-K/A XBRL

FORM 8-K/A

Company: Theravance Biopharma, Inc.
Filed: November 14, 2022
Period of Report: July 20, 2022
Accession Number: 0001104659-22-117504

View Document ↗ View on SEC.gov ↗